Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant

Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant

The experimental vaccine for bovine malignant catarrhal fever consists of viable attenuated alcelaphine herpesvirus 1 (AlHV-1) derived by extensive culture passage, combined with an oil-in-water adjuvant, delivered intramuscularly. This immunisation strategy was over 80% effective in previous experi...

Full description

Bibliographic Details
Main Authors: George C. Russell, David M. Haig, Mark P. Dagleish, Helen Todd, Ann Percival, Dawn M. Grant, Jackie Thomson, Anna E. Karagianni, Julio Benavides
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Vaccine: X
Subjects:
Malignant catarrhal fever
Vaccine
Emulsigen
Inactivation
Antigen
Antibody
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136221000073

Internet

http://www.sciencedirect.com/science/article/pii/S2590136221000073

Similar Items